EPR Characterization of Copper(II) Complexes of PAMAM-Py Dendrimers for Biocatalysis in the Absence and Presence of Reducing Agents and a Spin Trap
- 14 November 2017
- journal article
- research article
- Published by American Chemical Society (ACS) in The Journal of Physical Chemistry B
- Vol. 121 (46) , 10498-10507
Abstract
Polyamidoamine (PAMAM) dendrimers at different generations (from G2 to G6) were functionalized with pyridine (Py) groups at the external surface, and their complexation behavior with Cu(II) at increasing molar ratios between the ions and the Py groups was analyzed in the absence and presence of reducing agents and a spin trap. These Cu(II)–dendrimer complexes may be used as antitumor and antiamyloidogenesis drugs, similarly to other Cu(II)–dendrimer complexes, and as biocatalysts. Indeed, they have revealed to selectively catalyze molecular oxygen reduction to generate reactive oxygen species (ROS). A computer-aided electron paramagnetic resonance (EPR) study of these complexes allowed us to identify different complexes by increasing the Cu(II)/Py molar ratio for the different generations. Binuclear EPR-silent complexes were formed at the highest generations. The differently complexed Cu(II) ions showed a different capability to be reduced, starting from the most exposed at the dendrimer surface bearing a stable Cu(II)–Py2 coordination. Cu(II)–G5 showed peculiar structural properties which probably favored its activity as biocatalyst. The spin trap was able to capture hydroxyl radicals, which became clearly EPR visible after all Cu(II) ions were reduced to Cu(I). This method may be used as a platform to study interactions of Cu(II) in nanosized macromolecules for biomedical purposes, mainly in biocatalysis involving redox reactions and formation of ROS.Keywords
Funding Information
- Ministry of Science and Technology, Taiwan
- Dipartimento Scienze Pure e Applicate, Universit? degli Studi di Urbino Carlo Bo
This publication has 24 references indexed in Scilit:
- Anticancer copper(II) phosphorus dendrimers are potent proapoptotic Bax activatorsEuropean Journal of Medicinal Chemistry, 2017
- Comparative EPR studies of Cu( ii )-conjugated phosphorous-dendrimers in the absence and presence of normal and cancer cellsRSC Advances, 2014
- Original Multivalent Copper(II)-Conjugated Phosphorus Dendrimers and Corresponding Mononuclear Copper(II) Complexes with Antitumoral ActivitiesMolecular Pharmaceutics, 2013
- Dendrimers, Dendrons, and Dendritic Polymers2012
- Dendrimers Designed for Functions: From Physical, Photophysical, and Supramolecular Properties to Applications in Sensing, Catalysis, Molecular Electronics, Photonics, and NanomedicineChemical Reviews, 2010
- Synthesis and cytotoxic activities of chloropyridylimineplatinum(II) and chloropyridyliminecopper(II) surface-functionalized poly(amidoamine) dendrimersJournal of Inorganic Biochemistry, 2010
- Dendrimers V2003
- Discovery of dendrimers and dendritic polymers: A brief historical perspective*Journal of Polymer Science Part A: Polymer Chemistry, 2002
- Dendrimers and Dendrons2001
- "Cascade"- and "Nonskid-Chain-like" Syntheses of Molecular Cavity TopologiesSynthesis, 1978